| ||||||||
|
Hydromorphone overdoseDefinitionThis is poisoning from taking an excessive amount of hydromorphone, a prescription medicine used to relieve severe pain. Alternative NamesDilaudid overdose; Palladone overdose Poisonous IngredientHydromorphone, a type of morphine. Hydromorphone is an opioid narcotic, which means it is an extremely powerful drug that can cause very deep sleep. Patients who are prescribed hydromorphone for pain should not drink alcohol. Alcohol increases dangerous side effects, and can lead to overdose symptoms. Where Found
NOTE: This list may not be all inclusive. SymptomsNervous system
Lungs Heart and blood
Gastrointestinal
Skin
Eyes, ears, nose, and throat
Warning: A severe overdose of hydromorphone can cause death. Home CareThis can be a serious overdose. Seek immediate medical help. Before Calling EmergencyDetermine the following information:
The National Poison Control Center (1-800-222-1222) can be called from anywhere in the United States. This national hotline number will let you talk to experts in poisoning. They will give you further instructions. This is a free and confidential service. All local poison control centers in the U.S. use this national number. You should call if you have any questions about poisoning or poison prevention. It does NOT need to be an emergency. You can call for any reason, 24 hours a day, 7 days a week. Take the container with you to the hospital, if possible. What to Expect at the Emergency RoomThe health care provider will measure and monitor the patient's vital signs, including temperature, pulse, breathing rate, and blood pressure. The patient may receive:
Outlook (Prognosis)Patients who quickly receive medicine to reverse the effect of hydromorphone can recover within 1 to 4 hours. ReferencesDrummer OH. Recent trends in narcotic deaths. Ther Drug Monit. 2005 Dec;27(6):738-40. Everett S. Narcotic toxity. eMedicine. January 7, 2005. Available at: http://www.emedicine.com/emerg/topic330.htm (accessed March 18, 2006). US Food and Drug Administration. FDA Asks Purdue Pharma to Withdraw Palladone for Safety Reasons. Rockville, MD: National Press Office; July 13, 2005. Release P05-42.
Review Date:
3/19/2006 Reviewed By: Janeen R. Azare, PhD, MSPH, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. Review provided by VeriMed Healthcare Network. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited. | |||||||
© Copyright HealthBasis 2006. All Rights Reserved. |